jRCT2031230362已完成不适用
Phase II study of HP-6050 in patients with delirium, psychomotor agitation, and irritability
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Japanese patients aged 18 years or older
- •Patients with risk factors such as delirium
排除标准
- •Patients with a serious disease that is life-threatening or requires emergency treatment
- •Patients who cannot undergo evaluation and observation under hospitalization
- •Patients who are not considered by the physician to require sedation with drugs
结局指标
主要结局
-
Sedation scale
次要结局
未报告次要终点
研究者
相似试验
尚未招募
2 期
Phase II study of HP-6050 in patients with delirium, psychomotor agitation, and irritabilityJPRN-jRCT2031230362Inakura Hiroshi30
未知
3 期
Phase 3 clinical study of DU-6859a in patients with respiratory tract infectioJPRN-jRCT2080220704DAIICHISANKYO Co.,Ltd.150
进行中（未招募）
不适用
A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy - CP4055-201A phase II clinical study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapyEUCTR2005-000690-22-SEClavis Pharma as42
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.